Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""PALACE, J"" wg kryterium: Autor


Tytuł :
Paediatric myasthenia gravis: Prognostic factors for drug free remission.
Autorzy :
Vecchio D; Neurosciences Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom; University of Piemonte Orientale, Novara 28100, Italy. Electronic address: .
Ramdas S; Department of Paediatric Neurology, Oxford Radcliffe Hospitals NHS Trust, Oxford OX3 9DU, United Kingdom.
Munot P; Dubowitz Neuromuscular Centre, Institute of Child Health and Great Ormond Street Hospital, London WC1N 1EH, United Kingdom.
Pitt M; Department of Clinical Neurophysiology, Great Ormond Street Hospital for Children NHS foundation Trust, London WC1N 3JH, United Kingdom.
Beeson D; Neurosciences Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom.
Knight R; Neurosciences Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom.
Rodríguez Cruz P; Neurosciences Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom.
Vincent A; Neurosciences Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom.
Jayawant S; Department of Paediatric Neurology, Oxford Radcliffe Hospitals NHS Trust, Oxford OX3 9DU, United Kingdom.
DeVile C; Department of Paediatric Neurology, Great Ormond Street Hospital, London WC1N 1EH, United Kingdom.
Buckley C; Neurosciences Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom.
Hilton-Jones D; Neurosciences Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom.
Robb S; Dubowitz Neuromuscular Centre, Institute of Child Health and Great Ormond Street Hospital, London WC1N 1EH, United Kingdom.
Palace J; Neurosciences Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom.
Pokaż więcej
Źródło :
Neuromuscular disorders : NMD [Neuromuscul Disord] 2020 Feb; Vol. 30 (2), pp. 120-127. Date of Electronic Publication: 2019 Nov 21.
Typ publikacji :
Journal Article
MeSH Terms :
Disease Progression*
Myasthenia Gravis*/blood
Myasthenia Gravis*/drug therapy
Myasthenia Gravis*/ethnology
Myasthenia Gravis*/physiopathology
Outcome Assessment, Health Care*/statistics & numerical data
Autoantibodies/*blood
Receptors, Cholinergic/*immunology
Adolescent ; Adult ; Age Factors ; Age of Onset ; Child ; Child, Preschool ; Female ; Follow-Up Studies ; Humans ; Male ; Prevalence ; Prognosis ; Remission Induction ; Retrospective Studies ; Severity of Illness Index ; Sex Factors ; United Kingdom/ethnology ; Young Adult
Czasopismo naukowe
Tytuł :
[MOG encephalomyelitis: international recommendations on diagnosis and antibody testing].
Autorzy :
Jarius S; AG Molekulare Neuroimmunologie, Neurologische Klinik, Universitätsklinikum Heidelberg, Otto-Meyerhof-Zentrum, Im Neuenheimer Feld 350, 69120, Heidelberg, Deutschland. .
Paul F; Experimental and Clinical Research Center, NeuroCure Clincial Research Center, und Berliner Institut für Gesundheitsforschung, Max-Delbrück-Zentrum für Molekulare Medizin und Charité - Universitätsmedizin Berlin, Gliedkörperschaft der Freien Universität Berlin und der Humboldt-Universität zu Berlin, Berlin, Deutschland.
Aktas O; Neurologische Klinik, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Deutschland.
Asgari N; Department of Neurology, University of Southern Denmark, Odense, Dänemark.
Dale RC; Children's Hospital at Westmead, University of Sydney, Sydney, Australien.
de Seze J; Department of Neurology, Hôpital de Hautepierre, Strasbourg Cedex, Frankreich.
Franciotta D; Neuroimmunology Laboratory, IRCCS Mondino Foundation, Pavia, Italien.
Fujihara K; Department of Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan.
Jacob A; The Walton Centre, Walton Centre NHS Foundation Trust, Liverpool, Großbritannien.
Kim HJ; Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Südkorea.
Kleiter I; Marianne-Strauß-Klinik, Behandlungszentrum Kempfenhausen für Multiple Sklerose Kranke gGmbH, Berg, Deutschland.
Kümpfel T; Institut für Klinische Neuroimmunologie, Ludwig-Maximilians-Universität, München, Deutschland.
Levy M; Department of Neurology, Johns Hopkins Hospital, Cleveland, USA.
Palace J; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, Großbritannien.
Ruprecht K; Klinik für Neurologie mit experimenteller Neurologie, Charité - Universitätsmedizin Berlin, Gliedkörperschaft der Freien Universität Berlin und der Humboldt-Universität zu Berlin, Berlin, Deutschland.
Saiz A; Service of Neurology, Hospital Clinic, and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spanien.
Trebst C; Neurologische Klinik, Medizinische Hochschule Hannover, Hannover, Deutschland.
Weinshenker BG; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Wildemann B; AG Molekulare Neuroimmunologie, Neurologische Klinik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland. .
Pokaż więcej
Transliterated Title :
MOG-Enzephalomyelitis: Internationale Empfehlungen zu Diagnose und Antikörpertestung.
Źródło :
Der Nervenarzt [Nervenarzt] 2018 Dec; Vol. 89 (12), pp. 1388-1399.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Autoantibodies*/blood
Encephalomyelitis*/blood
Encephalomyelitis*/diagnosis
Neuromyelitis Optica*/blood
Neuromyelitis Optica*/diagnosis
Optic Neuritis*
Aquaporin 4 ; Expert Testimony ; Humans ; Myelin-Oligodendrocyte Glycoprotein/immunology
Czasopismo naukowe
Tytuł :
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.
Autorzy :
Jarius S; Molecular Neuroimmunology Group, Department of Neurology, University Hospital Heidelberg, Im Neuenheimer Feld 350, 69120, Heidelberg, Germany. .
Paul F; Department of Neurology and Clinical and Experimental Multiple Sclerosis Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.; NeuroCure Clinical Research Center and Clinical and Experimental Multiple Sclerosis Research Center, Berlin, Germany.
Aktas O; Department of Neurology, University of Düsseldorf, Düsseldorf, Germany.
Asgari N; Department of Neurology, University of Southern Denmark, Odense, Denmark.
Dale RC; Children's Hospital at Westmead, University of Sydney, Sydney, Australia.
de Seze J; Department of Neurology, Hôpital de Hautepierre, Strasbourg Cedex, France.
Franciotta D; IRCCS, National Neurological Institute C. Mondino, Pavia, Italy.
Fujihara K; Department of Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan.
Jacob A; The Walton Centre, Walton Centre NHS Foundation Trust, Liverpool, UK.
Kim HJ; Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, South Korea.
Kleiter I; Department of Neurology, Ruhr University Bochum, Bochum, Germany.
Kümpfel T; Institute of Clinical Neuroimmunology, Ludwig Maximilian University, Munich, Germany.
Levy M; Department of Neurology, Johns Hopkins Hospital, Cleveland, USA.
Palace J; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Ruprecht K; Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Saiz A; Service of Neurology, Hospital Clinic, and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
Trebst C; Department of Neurology, Hannover Medical School, Hanover, Germany.
Weinshenker BG; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Wildemann B; Molecular Neuroimmunology Group, Department of Neurology, University Hospital Heidelberg, Im Neuenheimer Feld 350, 69120, Heidelberg, Germany. .
Pokaż więcej
Źródło :
Journal of neuroinflammation [J Neuroinflammation] 2018 May 03; Vol. 15 (1), pp. 134. Date of Electronic Publication: 2018 May 03.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Internationality*
Autoantibodies/*blood
Encephalomyelitis/*blood
Encephalomyelitis/*diagnosis
Immunoglobulin G/*blood
Myelin-Oligodendrocyte Glycoprotein/*blood
Animals ; Biomarkers/blood ; Humans ; Immunoenzyme Techniques/methods ; Immunoenzyme Techniques/trends
Czasopismo naukowe
Tytuł :
Endocrinopathies in paediatric-onset neuromyelitis optica spectrum disorder with aquaporin 4 (AQP4) antibody.
Autorzy :
Hacohen Y; Department of Paediatric Neurology, Great Ormond Street Hospital for Children, London, UK/Department of Neuroinflammation, Queen Square Multiple Sclerosis Centre, UCL Institute of Neurology, London, UK/Department of Neurosciences, Great Ormond Street Hospital for Children, London, UK.
Messina S; Neurology Department, John Radcliffe Hospital, Oxford, UK.
Gan HW; Department of Paediatric Endocrinology, Great Ormond Street Hospital, London, UK.
Wright S; Department of Paediatric Neurology, Birmingham Children's Hospital, Birmingham, UK.
Chandratre S; Department of Paediatric Neurology, John Radcliffe Hospital, Oxford, UK.
Leite MI; Neurology Department, John Radcliffe Hospital, Oxford, UK/Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Fallon P; Department of Paediatric Neurology, St George's Hospital, London, UK.
Vincent A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Ciccarelli O; Department of Neuroinflammation, Queen Square Multiple Sclerosis Centre, UCL Institute of Neurology, London, UK.
Wassmer E; Department of Paediatric Neurology, Birmingham Children's Hospital, Birmingham, UK.
Lim M; Department of Children's Neurosciences, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, King's Health Partners Academic Health Science Centre, London, UK.
Palace J; Neurology Department, John Radcliffe Hospital, Oxford, UK.
Hemingway C; Department of Paediatric Neurology, Great Ormond Street Hospital for Children, London, UK.
Pokaż więcej
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2018 Apr; Vol. 24 (5), pp. 679-684. Date of Electronic Publication: 2017 Aug 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Autoantibodies*
Immunologic Factors*
Aquaporin 4/*immunology
Endocrine System Diseases/*epidemiology
Neuromyelitis Optica/*epidemiology
Neuromyelitis Optica/*immunology
Adolescent ; Amenorrhea/epidemiology ; Amenorrhea/etiology ; Caribbean Region/epidemiology ; Child ; Cohort Studies ; Endocrine System Diseases/etiology ; Female ; Humans ; Hyperandrogenism/epidemiology ; Hyperandrogenism/etiology ; Hyperinsulinism/epidemiology ; Hyperinsulinism/etiology ; Hyponatremia/epidemiology ; Hyponatremia/etiology ; Hypothalamus/diagnostic imaging ; Hypothalamus/pathology ; Hypothyroidism/epidemiology ; Hypothyroidism/etiology ; Magnetic Resonance Imaging ; Male ; Morbidity ; Neuromyelitis Optica/complications ; Neuromyelitis Optica/diagnostic imaging ; Obesity, Morbid/epidemiology ; Obesity, Morbid/etiology ; Prevalence ; Quality of Life
Czasopismo naukowe
Tytuł :
Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Autorzy :
Hacohen Y; Department of Neuroinflammation, Queen Square Multiple Sclerosis Centre, University College London Institute of Neurology, London, United Kingdom.; Department of Paediatric Neurology, Great Ormond Street Hospital for Children, London, United Kingdom.
Wong YY; Department of Neurology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Lechner C; Division of Paediatric Neurology, Department of Paediatrics, Medical University of Innsbruck, Innsbruck, Austria.
Jurynczyk M; Neurology Department, John Radcliffe Hospital, Oxford, United Kingdom.
Wright S; Department of Paediatric Neurology, Birmingham Children's Hospital, Birmingham, United Kingdom.
Konuskan B; Division of Pediatric Neurology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Kalser J; Centre Hospitalier, Universitaire Vaudois of Lausanne, Lausanne, Switzerland.
Poulat AL; Department of Pediatric Neurology, Groupement Hospitalier Est, Hospices Civils de Lyon, Lyon, France.
Maurey H; National Referral Center for Neuro-Inflammatory Diseases and Pediatric Neurology Department, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.; Service de Neuropédiatrie, University Paris Sud, Le Kremlin-Bicêtre, France.
Ganelin-Cohen E; Pediatric Neurology Unit, Schneider Children's Medical Center, Tel-Aviv, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Wassmer E; Department of Paediatric Neurology, Birmingham Children's Hospital, Birmingham, United Kingdom.
Hemingway C; Department of Paediatric Neurology, Great Ormond Street Hospital for Children, London, United Kingdom.
Forsyth R; Institute of Neuroscience, Newcastle University, Newcastle, United Kingdom.
Hennes EM; Department of Pediatrics, Olga Hospital, Stuttgart, Germany.
Leite MI; Neurology Department, John Radcliffe Hospital, Oxford, United Kingdom.
Ciccarelli O; Department of Neuroinflammation, Queen Square Multiple Sclerosis Centre, University College London Institute of Neurology, London, United Kingdom.
Anlar B; Division of Pediatric Neurology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Hintzen R; Department of Neurology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Marignier R; Service de Neurologie A and Eugène Devic Foundation Against Multiple Sclerosis, Observatoire Français de la Sclérose en Plaques, Hôpital Neurologique Pierre Wertheimer-Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.; Lyon's Neuroscience Research Center, INSERM U 1028/Centre National de la Recherche Scientifique 5292, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Palace J; Neurology Department, John Radcliffe Hospital, Oxford, United Kingdom.
Baumann M; Division of Paediatric Neurology, Department of Paediatrics, Medical University of Innsbruck, Innsbruck, Austria.
Rostásy K; Department of Pediatric Neurology, Children's Hospital Datteln, University Witten/Herdecke, Witten, Germany.
Neuteboom R; Department of Neurology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Deiva K; National Referral Center for Neuro-Inflammatory Diseases and Pediatric Neurology Department, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
Lim M; Children's Neurosciences, Evelina London Children's Hospital at Guy's and St Thomas' National Health Service Foundation Trust, King's Health Partners Academic Health Science Centre, London, United Kingdom.; Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Pokaż więcej
Źródło :
JAMA neurology [JAMA Neurol] 2018 Apr 01; Vol. 75 (4), pp. 478-487.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neuromyelitis Optica*/blood
Neuromyelitis Optica*/drug therapy
Neuromyelitis Optica*/immunology
Treatment Outcome*
Autoantibodies/*blood
Immunologic Factors/*therapeutic use
Myelin-Oligodendrocyte Glycoprotein/*immunology
Cohort Studies ; Disability Evaluation ; Europe ; Female ; Humans ; International Cooperation ; Male ; Mercaptopurine/analogs & derivatives ; Mercaptopurine/therapeutic use ; Mycophenolic Acid/therapeutic use ; Recurrence ; Rituximab/therapeutic use
Czasopismo naukowe
Tytuł :
Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica.
Autorzy :
Wilson R; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Makuch M; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Kienzler AK; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Varley J; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Taylor J; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Woodhall M; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Palace J; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.; Oxford University Hospitals, John Radcliffe Hospital, Oxford, OX3 9DS, UK.
Leite MI; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.; Oxford University Hospitals, John Radcliffe Hospital, Oxford, OX3 9DS, UK.
Waters P; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.; Oxford University Hospitals, John Radcliffe Hospital, Oxford, OX3 9DS, UK.
Irani SR; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.; Oxford University Hospitals, John Radcliffe Hospital, Oxford, OX3 9DS, UK.
Pokaż więcej
Źródło :
Brain : a journal of neurology [Brain] 2018 Apr 01; Vol. 141 (4), pp. 1063-1074.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Video-Audio Media
MeSH Terms :
Aquaporin 4/*immunology
Autoantibodies/*blood
B-Lymphocytes/*metabolism
Neuromyelitis Optica/*blood
Neuromyelitis Optica/*pathology
Adult ; Aged ; Cells, Cultured ; Correlation of Data ; Cytokines/metabolism ; Female ; Flow Cytometry ; Humans ; Interferon Regulatory Factors/genetics ; Interferon Regulatory Factors/metabolism ; Male ; Middle Aged ; PAX5 Transcription Factor/genetics ; PAX5 Transcription Factor/metabolism ; Proto-Oncogene Proteins c-bcl-6/genetics ; Proto-Oncogene Proteins c-bcl-6/metabolism ; RNA, Messenger/metabolism ; X-Box Binding Protein 1/genetics ; X-Box Binding Protein 1/metabolism
Czasopismo naukowe
Tytuł :
Serological and experimental studies in different forms of myasthenia gravis.
Autorzy :
Vincent A; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Huda S; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Cao M; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Cetin H; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Koneczny I; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Rodriguez Cruz PM; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Jacobson L; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Viegas S; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Jacob S; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Woodhall M; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Nagaishi A; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Maniaol A; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Damato V; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Leite MI; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Cossins J; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Webster R; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Palace J; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Beeson D; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Pokaż więcej
Źródło :
Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2018 Feb; Vol. 1413 (1), pp. 143-153. Date of Electronic Publication: 2018 Jan 29.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Autoantibodies/*immunology
Myasthenia Gravis/*immunology
Receptor Protein-Tyrosine Kinases/*immunology
Receptors, Cholinergic/*immunology
Agrin/immunology ; Humans ; Immunoglobulin G/immunology ; Kv1.4 Potassium Channel/immunology ; LDL-Receptor Related Proteins/immunology ; Myasthenia Gravis/classification
Czasopismo naukowe
Tytuł :
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
Autorzy :
Jurynczyk M; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.; Department of Neurology, Medical University of Lodz, Lodz, Poland.
Probert F; Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK. .
Yeo T; Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK.; Department of Neurology, National Neuroscience Institute, 11 Jalan Tan Tock Seng, Singapore, 308433, Singapore.
Tackley G; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
Claridge TDW; Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Mansfield Road, Oxford, OX1 3TA, UK.
Cavey A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
Woodhall MR; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
Arora S; Mathematical Institute, University of Oxford, Woodstock Rd, Oxford, OX2 6GC, UK.
Winkler T; Numares AG, Am Biopark 9, 93053, Regensburg, Germany.
Schiffer E; Numares AG, Am Biopark 9, 93053, Regensburg, Germany.
Vincent A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
DeLuca G; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
Sibson NR; Cancer Research UK & Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, OX37DQ, Oxford, UK.
Isabel Leite M; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
Waters P; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
Anthony DC; Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK. .
Palace J; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK. jacqueline.palace@ndcn.ox.ac.uk.
Pokaż więcej
Źródło :
Acta neuropathologica communications [Acta Neuropathol Commun] 2017 Dec 06; Vol. 5 (1), pp. 95. Date of Electronic Publication: 2017 Dec 06.
Typ publikacji :
Journal Article
MeSH Terms :
Aquaporin 4/*immunology
Autoantibodies/*blood
Metabolomics/*methods
Multiple Sclerosis, Relapsing-Remitting/*metabolism
Myelin-Oligodendrocyte Glycoprotein/*immunology
Neuromyelitis Optica/*metabolism
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Lipoproteins/classification ; Magnetic Resonance Spectroscopy ; Male ; Middle Aged ; Multiple Sclerosis, Relapsing-Remitting/diagnosis ; Multiple Sclerosis, Relapsing-Remitting/immunology ; Neuromyelitis Optica/diagnosis ; Neuromyelitis Optica/immunology ; Young Adult
Czasopismo naukowe
Tytuł :
Clinical presentation and prognosis in MOG-antibody disease: a UK study.
Autorzy :
Jurynczyk M; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Messina S; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Woodhall MR; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Raza N; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Everett R; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Roca-Fernandez A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Tackley G; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Hamid S; NMO Clinical Service, The Walton Centre, Liverpool, UK.
Sheard A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Reynolds G; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Chandratre S; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Hemingway C; Department of Neurology, Great Ormond Street Hospital for Children, London, UK.
Jacob A; NMO Clinical Service, The Walton Centre, Liverpool, UK.
Vincent A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Leite MI; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Waters P; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Palace J; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Pokaż więcej
Źródło :
Brain : a journal of neurology [Brain] 2017 Dec 01; Vol. 140 (12), pp. 3128-3138.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Autoantibodies/*blood
Myelin-Oligodendrocyte Glycoprotein/*blood
Neuromyelitis Optica/*blood
Neuromyelitis Optica/*epidemiology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Cohort Studies ; Disabled Persons ; Female ; Humans ; Infant ; Male ; Middle Aged ; Neuromyelitis Optica/diagnosis ; Prognosis ; United Kingdom/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.
Autorzy :
Jurynczyk M; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Geraldes R; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Probert F; Department of Pharmacology, University of Oxford, Oxford, UK.
Woodhall MR; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Waters P; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Tackley G; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
DeLuca G; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Chandratre S; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Leite MI; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Vincent A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Palace J; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Pokaż więcej
Źródło :
Brain : a journal of neurology [Brain] 2017 Mar 01; Vol. 140 (3), pp. 617-627.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Central Nervous System Diseases*/immunology
Central Nervous System Diseases*/metabolism
Aquaporin 4/*immunology
Autoantibodies/*metabolism
Brain/*diagnostic imaging
Multiple Sclerosis/*diagnostic imaging
Myelin-Oligodendrocyte Glycoprotein/*immunology
Adolescent ; Adult ; Age Factors ; Child ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Multiple Sclerosis/immunology ; Multiple Sclerosis/metabolism ; Neuromyelitis Optica/diagnostic imaging ; Neuromyelitis Optica/metabolism ; Principal Component Analysis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Pain in patients with transverse myelitis and its relationship to aquaporin 4 antibody status.
Autorzy :
Kong Y; Oxford Centre for Functional Magnetic Resonance Imaging of the Brain (FMRIB), University of Oxford, Oxford, UK; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Okoruwa H; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Revis J; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Tackley G; Oxford Centre for Functional Magnetic Resonance Imaging of the Brain (FMRIB), University of Oxford, Oxford, UK; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Leite MI; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Lee M; Oxford Centre for Functional Magnetic Resonance Imaging of the Brain (FMRIB), University of Oxford, Oxford, UK; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Tracey I; Oxford Centre for Functional Magnetic Resonance Imaging of the Brain (FMRIB), University of Oxford, Oxford, UK; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Palace J; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. Electronic address: jacqueline.palace@ndcn.ox.ac.uk.
Pokaż więcej
Źródło :
Journal of the neurological sciences [J Neurol Sci] 2016 Sep 15; Vol. 368, pp. 84-8. Date of Electronic Publication: 2016 Jun 23.
Typ publikacji :
Journal Article
MeSH Terms :
Aquaporin 4/*immunology
Autoantibodies/*metabolism
Myelitis, Transverse/*immunology
Pain/*immunology
Adult ; Aged ; Anxiety/immunology ; Catastrophization/immunology ; Depression/immunology ; Disability Evaluation ; Female ; Humans ; Linear Models ; Male ; Middle Aged ; Myelitis, Transverse/complications ; Myelitis, Transverse/psychology ; Pain/complications ; Pain/psychology ; Pain Measurement ; Psychiatric Status Rating Scales ; Quality of Life ; Surveys and Questionnaires ; Young Adult
Czasopismo naukowe
Tytuł :
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.
Autorzy :
Waters P; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Reindl M; Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Saiz A; Neuroimmunology Program, Hospital Clinic and Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
Schanda K; Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Tuller F; Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Kral V; Zdravotni ustav se sidlem v Usti nad Labem, Centrum imunologie a mikrobiologie, Usti nad Labem, Czech Republic.
Nytrova P; Department of Neurology, Center of Clinical Neuroscience First Faculty of Medicine, General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Sobek O; Laboratory for CSF and Neuroimmunology, Topelex Ltd, Prague, Czech Republic.
Nielsen HH; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Barington T; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Lillevang ST; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Illes Z; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark Department of Neurology, University of Pécs, Pécs, Hungary.
Rentzsch K; Euroimmun AG, Lübeck, Germany.
Berthele A; Klinikum rechts der Isar der TU München, Klinik für Neurologie, Munich, Germany.
Berki T; Department of Immunology and Biotechnology, University of Pécs, Pécs, Hungary.
Granieri L; Clinical Neurobiology Unit, Neuroscience Institute Cavalieri Ottolenghi (NICO), University Hospital San Luigi Gonzaga, Regional Referring Multiple Sclerosis Centre, Orbassano, Italy.
Bertolotto A; Clinical Neurobiology Unit, Neuroscience Institute Cavalieri Ottolenghi (NICO), University Hospital San Luigi Gonzaga, Regional Referring Multiple Sclerosis Centre, Orbassano, Italy.
Giometto B; Department of Neurology, Azienda ULSS 9 Treviso, Treviso, Italy.
Zuliani L; Department of Neurology, Azienda ULSS 9 Treviso, Treviso, Italy.
Hamann D; Sanquin Diagnostic Services, Department of Immunopathology and Blood Coagulation, Amsterdam, The Netherlands.
van Pelt ED; Department of Neurology, MS Centre ErasMS, Erasmus MC, Rotterdam, The Netherlands.
Hintzen R; Department of Neurology, MS Centre ErasMS, Erasmus MC, Rotterdam, The Netherlands.
Höftberger R; Neuroimmunology Program, Hospital Clinic and Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain Institute of Neurology, Medical University of Vienna, Vienna, Austria.
Costa C; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Comabella M; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Montalban X; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Tintoré M; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Siva A; Neurology Department, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey.
Altintas A; Neurology Department, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey.
Deniz G; Department of Immunology, Istanbul University, Institute of Experimental Medicine, Istanbul, Turkey.
Woodhall M; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Palace J; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Paul F; NeuroCure Clinical Research Center (NCRC), Charité Universitätsmedizin Berlin, Berlin, Germany.
Hartung HP; Medical Faculty, Department of Neurology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Aktas O; Medical Faculty, Department of Neurology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Jarius S; Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Germany.
Wildemann B; Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Germany.
Vedeler C; Department of Clinical Medicine, University of Bergen, Bergen, Norway Department of Neurology, Haukeland University Hospital, Bergen, Norway.
Ruiz A; Faculty of Medecine RTH Laennec, Lyon Neurosciences Research Centre, Neuro-inflammation and Neuro-oncology Team, Lyon, France.
Leite MI; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Trillenberg P; Department of Neurology, University Hospital of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
Probst M; Institute for Quality Assurance, Lübeck, Germany.
Saschenbrecker S; Euroimmun AG, Lübeck, Germany.
Vincent A; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Marignier R; Faculty of Medecine RTH Laennec, Lyon Neurosciences Research Centre, Neuro-inflammation and Neuro-oncology Team, Lyon, France.
Pokaż więcej
Źródło :
Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2016 Sep; Vol. 87 (9), pp. 1005-15. Date of Electronic Publication: 2016 Apr 25.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Aquaporin 4/*blood
Autoantibodies/*blood
Neuromyelitis Optica/*blood
Aquaporin 4/immunology ; Autoantibodies/immunology ; Enzyme-Linked Immunosorbent Assay/methods ; Humans ; Immunohistochemistry/methods ; Neuromyelitis Optica/immunology ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.
Autorzy :
Piccolo L; Nuffield Department of Clinical Neurosciences, Level 3 West Wing, Oxford University Hospitals NHS Trust, University of Oxford, Headley Way, Oxford, OX3 9DU, UK.; IRCCS C. Mondino, University of Pavia, Pavia, Italy.
Woodhall M; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Level 6 West Wing, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK.
Tackley G; Nuffield Department of Clinical Neurosciences, Level 3 West Wing, Oxford University Hospitals NHS Trust, University of Oxford, Headley Way, Oxford, OX3 9DU, UK.
Juryńczyk M; Nuffield Department of Clinical Neurosciences, Level 3 West Wing, Oxford University Hospitals NHS Trust, University of Oxford, Headley Way, Oxford, OX3 9DU, UK.
Kong Y; FMRIB Centre, John Radcliffe Hospital, Oxford University, Headington, Oxford, OX3 9DU, UK.
Domingos J; Nuffield Department of Clinical Neurosciences, Level 3 West Wing, Oxford University Hospitals NHS Trust, University of Oxford, Headley Way, Oxford, OX3 9DU, UK.; Centro Hospitalar do Porto, Hospital de Santo António, Serviço de Neurologia, Porto, Portugal.
Gore R; Nuffield Department of Clinical Neurosciences, Level 3 West Wing, Oxford University Hospitals NHS Trust, University of Oxford, Headley Way, Oxford, OX3 9DU, UK.
Vincent A; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Level 6 West Wing, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK.
Waters P; Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Level 6 West Wing, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK.
Leite MI; Nuffield Department of Clinical Neurosciences, Level 3 West Wing, Oxford University Hospitals NHS Trust, University of Oxford, Headley Way, Oxford, OX3 9DU, UK.
Palace J; Nuffield Department of Clinical Neurosciences, Level 3 West Wing, Oxford University Hospitals NHS Trust, University of Oxford, Headley Way, Oxford, OX3 9DU, UK. jacqueline.palace@ndcn.ox.ac.uk.
Pokaż więcej
Źródło :
Journal of neurology [J Neurol] 2016 Feb; Vol. 263 (2), pp. 370-379. Date of Electronic Publication: 2015 Dec 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Autoantibodies/*blood
Neuromyelitis Optica/*diagnosis
Neuromyelitis Optica/*immunology
Adolescent ; Adult ; Aquaporin 4/immunology ; Autoantigens/immunology ; Child ; Child, Preschool ; Female ; Humans ; Immunoglobulin G/blood ; Male ; Middle Aged ; Myelin-Oligodendrocyte Glycoprotein/immunology ; Neuromyelitis Optica/blood ; Optic Neuritis/blood ; Optic Neuritis/diagnosis ; Optic Neuritis/immunology ; Prognosis ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis.
Autorzy :
Rodríguez Cruz PM; Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, England2Neurosciences Group, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, England.
Al-Hajjar M; Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, England.
Huda S; Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, England.
Jacobson L; Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, England.
Woodhall M; Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, England.
Jayawant S; Department of Paediatric Neurology, Children's Hospital, John Radcliffe Hospital, Oxford, England.
Buckley C; Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, England.
Hilton-Jones D; Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, England.
Beeson D; Neurosciences Group, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, England.
Vincent A; Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, England.
Leite MI; Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, England.
Palace J; Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, England.
Pokaż więcej
Źródło :
JAMA neurology [JAMA Neurol] 2015 Jun; Vol. 72 (6), pp. 642-9.
Typ publikacji :
Journal Article
MeSH Terms :
Autoantibodies*
Myasthenia Gravis/*diagnosis
Receptors, Cholinergic/*immunology
Adolescent ; Adult ; Age of Onset ; Biological Assay/standards ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Middle Aged ; Myasthenia Gravis/immunology ; Myasthenia Gravis/physiopathology ; Phenotype ; Sensitivity and Specificity ; Severity of Illness Index ; Young Adult
Czasopismo naukowe
Tytuł :
Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
Autorzy :
Kitley J; Nuffield Department of Clinical Neurosciences, Oxford University Hospitals NHS Trust, University of Oxford, Oxford, England.
Waters P; Nuffield Department of Clinical Neurosciences, Oxford University Hospitals NHS Trust, University of Oxford, Oxford, England.
Vincent A; Nuffield Department of Clinical Neurosciences, Oxford University Hospitals NHS Trust, University of Oxford, Oxford, England.
Palace J; Nuffield Department of Clinical Neurosciences, Oxford University Hospitals NHS Trust, University of Oxford, Oxford, England.
Pokaż więcej
Źródło :
JAMA neurology [JAMA Neurol] 2014 Jul 01; Vol. 71 (7), pp. 924.
Typ publikacji :
Letter; Comment
MeSH Terms :
Aquaporin 4/*immunology
Autoantibodies/*blood
Myelin-Oligodendrocyte Glycoprotein/*immunology
Neuromyelitis Optica/*immunology
Female ; Humans ; Male
Opinia redakcyjna
Tytuł :
Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
Autorzy :
Kitley J; Nuffield Department of Clinical Neurosciences, Oxford University Hospitals National Health Service Trust, University of Oxford, Oxford, England.
Waters P; Nuffield Department of Clinical Neurosciences, Oxford University Hospitals National Health Service Trust, University of Oxford, Oxford, England.
Woodhall M; Nuffield Department of Clinical Neurosciences, Oxford University Hospitals National Health Service Trust, University of Oxford, Oxford, England.
Leite MI; Nuffield Department of Clinical Neurosciences, Oxford University Hospitals National Health Service Trust, University of Oxford, Oxford, England.
Murchison A; Nuffield Department of Clinical Neurosciences, Oxford University Hospitals National Health Service Trust, University of Oxford, Oxford, England.
George J; Nuffield Department of Clinical Neurosciences, Oxford University Hospitals National Health Service Trust, University of Oxford, Oxford, England.
Küker W; Department of Neuroradiology, Oxford University Hospitals National Health Service Trust, Oxford, England.
Chandratre S; Children's Hospital, Oxford University Hospitals National Health Service Trust, Oxford, England.
Vincent A; Nuffield Department of Clinical Neurosciences, Oxford University Hospitals National Health Service Trust, University of Oxford, Oxford, England.
Palace J; Nuffield Department of Clinical Neurosciences, Oxford University Hospitals National Health Service Trust, University of Oxford, Oxford, England.
Pokaż więcej
Źródło :
JAMA neurology [JAMA Neurol] 2014 Mar; Vol. 71 (3), pp. 276-83.
Typ publikacji :
Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Aquaporin 4/*immunology
Autoantibodies/*blood
Myelin-Oligodendrocyte Glycoprotein/*immunology
Neuromyelitis Optica/*immunology
Adult ; Age Factors ; Age of Onset ; Alcohol Oxidoreductases ; DNA-Binding Proteins ; Disability Evaluation ; Female ; Follow-Up Studies ; Hirudins ; Humans ; Male ; Middle Aged ; Neuromyelitis Optica/blood ; Neuromyelitis Optica/cerebrospinal fluid ; Neuromyelitis Optica/pathology ; Recombinant Proteins ; Severity of Illness Index ; Sex Factors ; Urokinase-Type Plasminogen Activator
Czasopismo naukowe
Tytuł :
Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.
Autorzy :
Kitley J; Nuffield Department of Clinical Neurosciences, Oxford University Hospitals NHS Trust, University of Oxford, Oxford, England.
Leite MI
Küker W
Quaghebeur G
George J
Waters P
Woodhall M
Vincent A
Palace J
Pokaż więcej
Źródło :
JAMA neurology [JAMA Neurol] 2013 Nov; Vol. 70 (11), pp. 1375-81.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Aquaporin 4/*immunology
Autoantibodies/*blood
Myelitis, Transverse/*blood
Myelitis, Transverse/*diagnosis
Neuromyelitis Optica/*blood
Adult ; Aged ; Female ; HEK293 Cells ; Humans ; Kaplan-Meier Estimate ; Longitudinal Studies ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Myelitis, Transverse/complications ; Myelitis, Transverse/physiopathology ; Neuromyelitis Optica/complications ; Neuromyelitis Optica/diagnosis ; Retrospective Studies ; Statistics, Nonparametric ; Transfection
Czasopismo naukowe
Tytuł :
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
Autorzy :
Matthews L; Nuffield Department of Clinical Neurosciences, University of Oxford, UK. />Marasco R
Jenkinson M
Küker W
Luppe S
Leite MI
Giorgio A
De Stefano N
Robertson N
Johansen-Berg H
Evangelou N
Palace J
Pokaż więcej
Źródło :
Neurology [Neurology] 2013 Apr 02; Vol. 80 (14), pp. 1330-7. Date of Electronic Publication: 2013 Mar 13.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Autoantibodies/*blood
Brain/*pathology
Multiple Sclerosis/*diagnosis
Neuromyelitis Optica/*diagnosis
Adult ; Aged ; Aquaporin 4/immunology ; Brain Mapping ; Cohort Studies ; Cross-Sectional Studies ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Multiple Sclerosis/blood ; Neuromyelitis Optica/blood ; Probability ; Young Adult
Czasopismo naukowe
Tytuł :
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Autorzy :
Kitley J; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Woodhall M
Waters P
Leite MI
Devenney E
Craig J
Palace J
Vincent A
Pokaż więcej
Źródło :
Neurology [Neurology] 2012 Sep 18; Vol. 79 (12), pp. 1273-7. Date of Electronic Publication: 2012 Aug 22.
Typ publikacji :
Journal Article
MeSH Terms :
Autoantibodies/*immunology
Myelin-Oligodendrocyte Glycoprotein/*immunology
Neuromyelitis Optica/*immunology
Adolescent ; Adult ; Aquaporin 4/immunology ; Autoantibodies/blood ; Female ; Humans ; Male ; Neuromyelitis Optica/blood
Czasopismo naukowe
Tytuł :
Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels.
Autorzy :
Stagg CJ; Centre for Functional Magnetic Resonance of the Brain (FMRIB), University of Oxford, Oxford, United Kingdom. />Lang B
Best JG
McKnight K
Cavey A
Johansen-Berg H
Vincent A
Palace J
Pokaż więcej
Źródło :
Epilepsia [Epilepsia] 2010 Sep; Vol. 51 (9), pp. 1898-901.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Autoantibodies/*blood
Cerebral Cortex/*metabolism
Epilepsy/*immunology
Glutamate Decarboxylase/*immunology
gamma-Aminobutyric Acid/*metabolism
Adult ; Aged ; Autoantibodies/metabolism ; Biomarkers/blood ; Cerebral Cortex/chemistry ; Epilepsy/blood ; Female ; Glutamate Decarboxylase/metabolism ; Glutamates/metabolism ; Humans ; Magnetic Resonance Spectroscopy ; Male ; Middle Aged ; gamma-Aminobutyric Acid/analysis
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies